Abiraterone: New Prostate Cancer Drug A new drug is being hailed as a potential breakthrough in the fight against prostate cancer, which kills 600 New Zealand men a year. The new drug called Abiraterone was trialled overseas and is being hailed as a potential breakthrough in the fight against prostate cancer. But experts in New Zealand are warning it's too soon to say if it really will live up to the hype. Doctors in Britain say Abiraterone represents a 'major step forward' in the treatment of highly aggressive prostate cancer which, before now, has been almost an untreatable disease. The quality of life of men in the trial, whose cancer was advanced and had spread to other parts of the body, improved markedly. ...

Cancer Vaccine From Tobacco Plant? In the first human trial of its kind, a vaccine grown in genetically engineered tobacco plants has proved to be safe, paving the way to one day use it to help combat a potentially fatal form of non-Hodgkin's lymphoma. Researchers report in the Proceedings of the National Academy of Sciences USA that the experimental vaccine triggered the immune systems of 11 of 16 volunteers (with so-called follicular B-cell lymphoma) to attack their tumors without any apparent dangerous side effects. Some 18,000 Americans, typically between the ages of 60 and 65, are diagnosed annually with this incurable, slow-growing type of cancer. Study coauthor Ronald Levy, an oncologist at the Stanford University School of Medicine, says that physicians generally take their cues from the disease, waiting to see how fast it is moving—and treating it with toxic chemotherapy (sometimes with radiation) only if it becomes aggressive. He says that if future trials are successful, the experimental vaccine, which can be made relatively quickly and cheaply, could become a short-term therapy administered immediately after diagnosis to try to keep tumors in check. "This may not be a replacement for chemotherapies, but a supplement for them," Levy says. "A technology that is fast, like this one, is more amenable to a watchful waiting approach than a technology that is slow to produce..."

Anderson Silva vs James Irvin sherdog.com: Silva and Irvin kick off the main event with Mario Yamasaki serving as referee. They meet in the center of the octagon with Silva scoring an inside leg kick. Silva is staying back mostly, looking for an opening while Irvin tries to stalk him around the cage. Irvin throws a leg kick but Silva catches it and lays Irvin out with a straight right. A quick blitz of punches on a prone Irvin forces Yamasaki to halt the contest at 1:01 of the first round.

sherdog.com: Josh Barnett scratched his seven-year itch, avenging a knockout loss to Pedro Rizzo from 2001 with a knockout of his own. It was a pinpoint left hook that sent Rizzo careening to the mat, where he lay prone at 1:44 of the second round.

Fedor rings Sylvia's bell just 36 seconds into Affliction bout usa today The main mixed martial arts event between heavyweights Fedor Emelianenko and Tim Sylvia at Affliction Banned ended almost as soon as it started. The two tapped hands when the bell rang and Emelianenko wasted no time taking the fight to Sylvia. The Russian delivered a powerful and speedy combination of rights and lefts that stunned and quickly knocked down Sylvia, who is eight inches taller and 33 pounds heavier...